Cover Image
Read Now

141
Published 2020
Canadian Agency for Drugs and Technologies in Health
“... of the least costly currently reimbursed medium- or high-dose ICS and a LABA and a long-acting muscarinic...”
Cover Image
Read Now

142
Published 2015
Canadian Agency for Drugs and Technologies in Health
“... fixeddose combination of a long‐acting muscarinic antagonist (LAMA), tiotropium, and a long-acting beta2...”
Cover Image
Read Now

143
Published 2015
Canadian Agency for Drugs and Technologies in Health
“...) or muscarinic antagonists (SAMAs, LAMAs) is a mainstay of COPD therapy. Aclidinium bromide (ACL) (Tudorza...”
Cover Image
Read Now

144
Published 2021
Canadian Agency for Drugs and Technologies in Health
“...-acting muscarinic antagonist (LAMA) treatments, the impact of adverse events (AEs) on the cost...”
Cover Image
Read Now

145
Published 1984
Springer US
“... and muscarinic cholinergic, and histami­ nergic. With the characterization of various types of receptors on cell...”